X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

HYPERTENSION

期刊標題檢索 HYPERTENSION 最新評論: Submitted on August 7th, it is still in the first round of review. Th... (2024-09-03)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[HYPERTENSION]您好,您是該頁面的第 80480 位訪客。

期刊簡介
期刊名稱HYPERTENSION HYPERTENSION
LetPub Score
9.0
50 ratings
Rate

Reputation
9.9

Influence
8.2

Speed
9.6

期刊簡稱HYPERTENSION
ISSN0194-911X
E-ISSN1524-4563
h-index246
CiteScore
CiteScoreSJRSNIPCiteScore Rank
15.902.8272.208
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Internal Medicine
Q112 / 167

自引率 (2023-2024)4.30%自引率趨勢
掲載範囲
Hypertension delivers some of the best high blood pressure-related articles in each monthly issue. Articles are focused on basic science, clinical treatment, and prevention of hypertension and related cardiovascular, metabolic and renal diseases, and are the papers which will prove their significance for years to come.

Online subscriptions are available to members of the American Heart Association/American Stroke Association as a benefit of membership depending on membership level.
官方網站https://www.ahajournals.org/journal/hyp
在線稿件提交https://hype-submit.aha-journals.org/cgi-bin/main.plex
開放訪問No
出版商Lippincott Williams and Wilkins Ltd.
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年1979
每年文章數248每年文章數趨勢
黃金OA百分比17.97%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PERIPHERAL VASCULAR DISEASESCIEQ16/96
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0194-911X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1 Month(s)
競爭力 *來自作者的數據: About 37.5%
參考鏈接
相關期刊 【HYPERTENSION】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CIRCULATIONH-index: 570

    CiteScore: 45.70
    CIRCULATION RESEARCHH-index: 306

    CiteScore: 29.60
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGYH-index: 251

    CiteScore: 15.60
    International Journal of StrokeH-index: 59

    CiteScore: 13.90
    JOURNAL OF THROMBOSIS AND HAEMOSTASISH-index: 154

    CiteScore: 24.30
    THROMBOSIS AND HAEMOSTASISH-index: 178

    CiteScore: 11.90
    ATHEROSCLEROSISH-index: 159

    CiteScore: 9.80
    HYPERTENSION RESEARCHH-index: 78

    CiteScore: 7.40
    CURRENT HYPERTENSION REPORTSH-index: 63

    CiteScore: 10.50
    THROMBOSIS RESEARCHH-index: 102

    CiteScore: 14.60
    學科內最受檢索的期刊 頁面查看次數
    CIRCULATION118498
    CIRCULATION RESEARCH93182
    ATHEROSCLEROSIS77472
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY66779
    JOURNAL OF HYPERTENSION51908
    THROMBOSIS RESEARCH43990
    HYPERTENSION RESEARCH42949
    THROMBOSIS AND HAEMOSTASIS38949
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS35890
    International Journal of Stroke35459
  •  

    HYPERTENSION HYPERTENSION
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [HYPERTENSION] 的評論撰寫評論
作者: duan_2020


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-03 08:26:46 評論於
Submitted on August 7th, it is still in the first round of review. The agonizing wait continues...
(0) 讚! | duan_2020

作者: 舒兰小仙女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-09 16:12:16 評論於
Same question, any results?
(0) 讚! | 舒兰小仙女

作者: 坠星倩影


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-03 13:46:30 評論於
Second External Audit
(0) 讚! | 坠星倩影

作者: 水月秀兰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-17 09:50:19 評論於
Please translate the following paragraph into English and Japanese, with the headings ":" and ":"
(0) 讚! | 水月秀兰

作者: 风芹小哥哥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-12 22:59:50 評論於
Is it considered under external review if the status changes from submitted to under review to decision back to under review? Or is it being reviewed by the associate editor?
(0) 讚! | 风芹小哥哥

作者: 风芹小哥哥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-12 16:19:43 評論於
Is it submitted--under review--decision--under review, that means it has been sent for external review? Or is it with the associate editor?
(0) 讚! | 风芹小哥哥

作者: 是昕雨吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-21 19:39:46 評論於
Hello! I would like to ask how long it takes from online to formal publication, thank you
(0) 讚! | 是昕雨吖

作者: 是昕雨吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-21 11:25:17 評論於
Hello! I would like to ask how long it takes from online to official publication, thank you
(0) 讚! | 是昕雨吖

作者: 邻家飞跃


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-06 23:53:07 評論於
Authoritative journal in the field of cardiovascular, difficult to submit, high quality articles required, need to have a certain level of innovation. Submission difficulty and article quality are both in the 7-9 range, without any superficial content. However, there is still a gap compared to CIRCULATION RESEARCH
(0) 讚! | 邻家飞跃

作者: 子睿Sama


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-08-08 18:53:10 評論於
#Cardiovascular# Pulmonary hypertension, 1st review for 12 days with three reviewers, major revision, resubmitted after two months, 2nd review for 2 days, one reviewer had questions, resubmitted after 2 days, 3rd review for 1 day, accepted, publishing requires great innovation and effort, not easy!
(0) 讚! | 子睿Sama

作者: 华清阏逢


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-04-17 13:03:16 評論於
Help: I need to find a supplement to an article in this magazine, how can I do that?
(0) 讚! | 华清阏逢

作者: 骨架雪磊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-12-04 12:15:28 評論於
Do you have the submission link of his? Can you share it with me?
(0) 讚! | 骨架雪磊

作者: Oliver Jerry


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-10-25 21:59:26 評論於
High accuracy of hit rate
(0) 讚! | Oliver Jerry

作者: 落雁正业


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-02-01 17:46:32 評論於
Review speed: 1.0 | Submission acceptance rate: 25.0
Sharing experience: Rejected after 3 weeks of review, feeling down
(0) 讚! | 落雁正业

作者: 东风采蓉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-01-25 19:56:30 評論於
Submission acceptance rate: 25.0 Experience sharing: I received an acceptance notification this morning. Hypertension is a very time-sensitive journal, with a review period of no more than 28 days. My article was given 3 months for minor revisions, with strict deadlines. If the article exceeds 3 months, it will be evaluated as a new submission. Our department has submitted a total of 15 articles from 2010 to now, with 3 accepted so far, which is close to the acceptance rate of this journal. Personally, I have submitted 2 articles, the first one in 2013. After a major revision and the requirement for further modifications, I gave up because I was facing my doctoral graduation at the time. Today's submission went smoothly, with minor revisions and feasible requests for additional experiments. It took about 2 months to complete all the required experiments, communicating solely through data
(0) 讚! | 东风采蓉

作者: yuxiufeng0806@126.com


領域: 生命科学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2018-01-25 13:28:15 評論於
Hypertension is a very time-sensitive journal. The review period is no longer than 28 days. My article was in minor revision for 3 months. Our department has submitted 15 articles from 2010 to the present, and currently had 3 articles accepted, which is close to the acceptance rate of this journal.

(0) 讚! | yuxiufeng0806@126.com

作者: pub


領域: 医药科学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2017-08-07 18:21:02 評論於
The problem of the external auditorA burst of blood, can not be evaded.It is very laborious to answer.It took 3 months to supplement the experiment, which was not delayed and the pressure was great.After the repair, the trial will be passed and received.
(1) 讚! | pub

作者: 一只珠玉呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-08-07 17:10:02 評論於
The questions from the external audit experts were incisive and could not be avoided. Answering them was very difficult. It took 3 months to complete the supplementary experiments, and there was no room for delay, so the pressure was high. After making revisions, it was re-audited and accepted
(0) 讚! | 一只珠玉呀

作者: Christine Housman


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-21 08:11:22 評論於
Review speed: 1.0 | Submission acceptance rate: 25.0 Experience sharing: The review speed is very fast, two weeks after submission, it was rejected with opinions from three reviewers
(0) 讚! | Christine Housman

作者: Nicola Cooke


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-04-07 19:08:56 評論於
Review speed: 3.0 | Submission acceptance rate: 25.0
Sharing experience: The latest published study on birth cohort, congenital heart research: The results of this study support and extend the findings of the early NBDPS, indicating a possible association between the use of antihypertensive medications and an increased risk of specific CHD, although we cannot completely rule out the confounding effects of potential disease characteristics
(0) 讚! | Nicola Cooke

作者: Nicola Cooke


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-04-07 12:03:46 評論於
Definitely not yet to external review. HSH1234 2016-03-13: Just submitted for one day, and the status changed to under review. Received an email (have begun the assignment/peer review process). As it's my first submission, I'd like to ask if this status means it has been sent out for review or if it's an initial editorial review. Please advise, thank you
(0) 讚! | Nicola Cooke

作者: Nicola Cooke


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-04-07 09:14:42 評論於
This issue should be dealt with rationally, and foreigners' programming thinking is very important. There are internal and external reviews, with technical review first and peer review later. The criteria examined at each level are different
(0) 讚! | Nicola Cooke

作者: qiye


領域: 医药科学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2017-02-07 15:49:30 評論於
One of the seven major flagship journals of the American Heart Association.The top mark journal in the field of cardiovascular research, the reviewers are all big cattle in the field, and the articles are more than the circulation research every year, but the review ratio is very low, so the impact factor is about 7 in recent years.There are few articles made in pure China, and research requires a combination of basic clinical methods, and model animals are often used.At the same time, research results need to be strongly innovative.The reviewer's question is sharp and unambiguous. It can be published in this journal. It has already explained the level of research and is a journal with great influence in the cardiovascular field.Articles charge a page fee, see the journal faster!The receiving ratio should be less than 10%.
(7) 讚! | qiye

作者: 金蛇怡君


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-01-17 14:19:24 評論於
Hello, may I ask if this magazine charges for page fees?
Anonymous, July 18, 2014: Research interests: epidemiology; clinical research; acceptance rate: about 5%; review time: about 1 month. Submitted an article on June 25th, on clinical aspects, with a relatively large sample size. Received first review in 14 days, with 2 reviewers requested. The first reviewer highly praised our research, only suggesting that we find a native English speaker to polish the language. The second reviewer raised 5 minor issues, including language and some very small details. Spent 2500 yuan on language editing, carefully answering the reviewers' questions, and resubmitted after 1 week. 2 days later, it was rejected, stating that although the research was good and the reviewers had no objections, it did not meet the priority conditions for publication. I have replied asking why we were asked to revise if the research did not meet the conditions for publication. Could it be just for the so-called language editing fee? I suggest to comrades, don't be fooled again. In the future, regardless of the journal, language should be the final thing to be modified. Let the editor check everything else first. If everything is okay, only then consider the language issue. It's not a big deal if it's just a language issue. Chinese-written SCIs are often criticized by foreigners for language issues, and you know the reason – the profits of the language editing companies. Although it failed, there are lessons learned to be shared with comrades
(0) 讚! | 金蛇怡君

作者: 金蛇怡君


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-01-17 13:19:28 評論於
Hello, could you please let me know if there is a page fee for this magazine?
(0) 讚! | 金蛇怡君

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [HYPERTENSION] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*